|Articles|February 10, 2023
SCOPE 2023: Synopsis of Biospecimen Sample Management Presentation
Author(s)Lisa Henderson
Hope Meely, chief clinical officer at Slope, provides a brief summary of her SCOPE presentation revolving around biospecimen collection.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Hope Meely, chief clinical officer at Slope, explains why biospecimens within the precision and personalized medicine spaces have become so valuable. Meely is coming off her conference presentation, "The Hidden Regulatory Risk from Sample Management — What Should You Be Aware of?”
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Worldwide Clinical Trials to Acquire Catalyst Clinical Research, Expanding Oncology and FSP Capabilities
2
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
3
How Real-World Evidence Will Change Trials Without Replacing Them
4
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
5